Literature DB >> 26294888

Important causes of chronic kidney disease in South Africa.

M R Moosa1, I Van der Walt, S Naicker, A M Meyers.   

Abstract

In hypertensive patients without chronic kidney disease (CKD) the goal is to keep blood pressure (BP) at ≤140/90 mmHg. When CKD ispresent, especially where there is proteinuria of ≥0.5 g/day, the goal is a BP of ≤130/80 mmHg. Lifestyle measures are mandatory, especiallylimitation of salt intake, ingestion of adequate quantities of potassium, and weight control. Patients with stages 4 - 5 CKD must be carefullymonitored for hyperkalaemia and deteriorating kidney function if angiotensin-converting enzyme (ACE) inhibitors or angiotensin IIreceptor blockers (ARBs) are used, especially in patients >60 years of age with diabetes or atherosclerosis. BP should be regularly monitoredand, where possible, home BP-measuring devices are recommended for optimal control.Guidelines on the use of antidiabetic agents in CKD are presented, with the warning that metformin is contraindicated in patients withstages 4 - 5 CKD.There is a wide clinical spectrum of renal disease in the course of HIV infection, including acute kidney injury, electrolyte and acid-basedisturbances, HIV-associated glomerular disease, acute-on-chronic renal disease and side-effects related to the treatment of HIV.

Entities:  

Year:  2015        PMID: 26294888     DOI: 10.7196/samj.9535

Source DB:  PubMed          Journal:  S Afr Med J


  10 in total

Review 1.  Chronic Kidney Disease among Diabetes Patients in Ethiopia: A Systematic Review and Meta-Analysis.

Authors:  Wondimeneh Shibabaw Shiferaw; Tadesse Yirga Akalu; Yared Asmare Aynalem
Journal:  Int J Nephrol       Date:  2020-10-10

2.  Eating Like a Rainbow: The Development of a Visual Aid for Nutritional Treatment of CKD Patients. A South African Project.

Authors:  Cecile Verseput; Giorgina Barbara Piccoli
Journal:  Nutrients       Date:  2017-04-28       Impact factor: 5.717

3.  Approach to acute kidney injury in HIV-infected patients in South Africa.

Authors:  Michael T Boswell; Theresa M Rossouw
Journal:  South Afr J HIV Med       Date:  2017-11-28       Impact factor: 2.744

4.  A Cost Analysis of Haemodialysis and Peritoneal Dialysis for the Management of End-Stage Renal Failure At an Academic Hospital in Pretoria, South Africa.

Authors:  Letlhogonolo Makhele; Moliehi Matlala; Mncengeli Sibanda; Antony P Martin; Brian Godman
Journal:  Pharmacoecon Open       Date:  2019-12

5.  Blood pressure control in hypertensive patients attending a rural community health centre in Gauteng Province, South Africa: A cross-sectional study.

Authors:  Sergius C Onwukwe; Nnabuike C Ngene
Journal:  S Afr Fam Pract (2004)       Date:  2022-03-28

Review 6.  Prevalence of chronic kidney disease and associated factors among patients with chronic illness in Ethiopia: A systematic review and meta-analysis.

Authors:  Zelalem Animaw; Gashaw Walle Ayehu; Hussen Abdu
Journal:  SAGE Open Med       Date:  2022-04-17

7.  Protection Effect of Exogenous Fibroblast Growth Factor 21 on the Kidney Injury in Vascular Calcification Rats.

Authors:  Yu-Chen Shi; Wei-Wei Lu; Yue-Long Hou; Kun Fu; Feng Gan; Shu-Juan Cheng; Shao-Ping Wang; Yong-Fen Qi; Jing-Hua Liu
Journal:  Chin Med J (Engl)       Date:  2018-03-05       Impact factor: 2.628

8.  An overview of tenofovir and renal disease for the HIV-treating clinician.

Authors:  Willem D F Venter; June Fabian; Charles Feldman
Journal:  South Afr J HIV Med       Date:  2018-07-17       Impact factor: 2.744

Review 9.  Contemporary issues and new challenges in chronic kidney disease amongst people living with HIV.

Authors:  Jack Edward Heron; Corinne Isnard Bagnis; David M Gracey
Journal:  AIDS Res Ther       Date:  2020-03-16       Impact factor: 2.250

10.  Relationship between amino acid ratios and decline in estimated glomerular filtration rate in diabetic and non-diabetic patients in South Africa.

Authors:  Thapelo Mbhele; Donald M Tanyanyiwa; Refilwe J Moepya; Sindeep Bhana; Maya M Makatini
Journal:  Afr J Lab Med       Date:  2021-12-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.